Skip to main content
. 2020 Feb 28;26(8):789–803. doi: 10.3748/wjg.v26.i8.789

Figure 1.

Figure 1

High immune scores and stromal scores are significantly associated with better prognosis in patients with hapetocellular carcinoma. A: Recurrence-free survival (RFS) between two groups based on immune scores; B: Overall survival (OS) between two groups based on immune scores; C: RFS between two groups based on stromal scores; D: OS between two groups based on stromal scores; E-J: Level of tumor-infiltrating immune cells in the two groups, including B cell, CD4+ T cell, CD8+ T cell, neutrophil, macrophage, and dendritic cell. There were 258 cases with high scores and 86 cases with low scores. aP = 6.9e-15, bP < 2.2e-16, cP = 8.8e-10. RFS: Recurrence-free survival; OS: Overall survival.